Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
Seyed Mehrab Safdari, Molecular Laboratory Technician at Tehran University of Medical Sciences, shared a post on LinkedIn ab0ut a recent article he and his colleagues co-authored, published in Haemophilia, adding:
“Thrombosis in a rare bleeding disorder?!
This paradox was one of the most intriguing aspects of my MSc thesis, where I investigated Factor VII Padua, an ultra-rare subtype of type II Factor VII deficiency caused by the F7 c.1091G>A (p.Arg364Gln) variant.
FVII Padua presents several diagnostic challenges:
- FVII activity is highly thromboplastin-dependent. Rabbit-brain thromboplastin may show severely reduced activity, while human-placental or recombinant human thromboplastins can yield substantially higher values.
- The clinical phenotype is highly variable, ranging from asymptomatic individuals to patients with mild or moderate bleeding.
- Thrombosis can occur despite markedly reduced FVII activity, making accurate diagnosis particularly important.
In our cohort of 150 Iranian patients with FVII deficiency, 13 (8.6%) showed PT patterns suggestive of FVII Padua. HRM identified 9 heterozygous and 2 homozygous cases, while sequencing confirmed the p.Arg364Gln variant in 2 patients. Four additional exon 9 variants were also identified.
The confirmed Padua cases showed diverse clinical manifestations, including bruising, epistaxis, gastrointestinal bleeding, and gum bleeding.
Therefore,accurate recognition of FVII Padua is essential because thromboplastin-dependent laboratory results may complicate diagnosis and potentially lead to unnecessary replacement therapy and increased thrombotic risk.
This project reinforced an important lesson in haemostasis:
A very low factor level does not always tell the whole story.”
Title: Factor VII Padua in Iran: A Study on 150 Patients With Factor VII Deficiency
Authors: Seyed Mehrab Safdari, Mahmood Barati, Soudabeh Hosseini, Ebrahim Kalantar, Farhad Zaker, Akbar Dorgalaleh
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide